(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia...
Stats | |
---|---|
Today's Volume | 2.54M |
Average Volume | 2.27M |
Market Cap | 88.07M |
EPS | $0 ( 2024-02-26 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.60 |
ATR14 | $0.00100 (1.04%) |
Volume Correlation
Neurotech International Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Neurotech International Correlation - Currency/Commodity
Neurotech International Financials
Annual | 2023 |
Revenue: | $5 959.00 |
Gross Profit: | $4 215.00 (70.73 %) |
EPS: | $-0.00980 |
Q2 | 2023 |
Revenue: | $1 507.00 |
Gross Profit: | $-949 196 (-62 985.80 %) |
EPS: | $-0.000800 |
Q4 | 2023 |
Revenue: | $2 971.00 |
Gross Profit: | $-2.21M (-74 311.54 %) |
EPS: | $-0.00500 |
Q3 | 2022 |
Revenue: | $-2 948.00 |
Gross Profit: | $-1.11M (37 596.07 %) |
EPS: | $-0.00250 |
Financial Reports:
No articles found.
Neurotech International
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators